Immune and viral correlates of "secondary viral control" after treatment interruption in chronically HIV-1 infected patients.
about
Can immunotherapy be useful as a "functional cure" for infection with Human Immunodeficiency Virus-1?Immune responses during spontaneous control of HIV and AIDS: what is the hope for a cure?Relationship of HIV reservoir characteristics with immune status and viral rebound kinetics in an HIV therapeutic vaccine study.Autograft HIV-DNA load predicts HIV-1 peripheral reservoir after stem cell transplantation for AIDS-related lymphoma patients.Impact of a decade of successful antiretroviral therapy initiated at HIV-1 seroconversion on blood and rectal reservoirs.Cell-associated HIV RNA: a dynamic biomarker of viral persistence.HIV-1 transcription and latency: an update.Translational HIV-1 research: from routine diagnostics to new virology insights in Amsterdam, the Netherlands during 1983-2013HIV controllers: a genetically determined or inducible phenotype?Post-Treatment Controllers: Role in HIV "Cure" Research.Brief Report: Prevalence of Posttreatment Controller Phenotype Is Rare in HIV-Infected Persons After Stopping Antiretroviral Therapy.Long-term antiretroviral therapy initiated during primary HIV-1 infection is key to achieving both low HIV reservoirs and normal T cell counts.What do we measure when we measure cell-associated HIV RNA.
P2860
Q26865388-C608E91B-2FF0-4D4B-BDDA-0F8811B11C70Q30362489-EFFDDE62-92C6-4C4E-98DB-833D0AC0314AQ34713877-12FBEFF2-7167-4D14-B62D-04C8485A9729Q34869326-69FCB65C-8563-49C9-8F72-42826826839FQ36311695-EF01EC14-5F2E-4554-A96E-C76200AB96E3Q36798408-722F65CC-4E0B-410B-87FE-781DCD39ACF9Q36976156-61C62234-4B65-4538-BC0D-653BD0D3191FQ37153174-CEF14848-F1EC-429B-ABF2-D99B8C828B21Q38114915-D2F0ECD4-3B80-4C2E-8BE5-7A1D302567B2Q38701493-2F42269A-4855-4721-8995-963D11F40D08Q40250340-A240D384-273B-4F10-BDEA-944003F426A7Q45930474-16919CEC-8DC2-41C3-A06F-646EB1CD23CAQ47548192-DA78800B-D9C0-4A9D-9733-C290F7BF5747
P2860
Immune and viral correlates of "secondary viral control" after treatment interruption in chronically HIV-1 infected patients.
description
2012 nî lūn-bûn
@nan
2012 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Immune and viral correlates of ...... cally HIV-1 infected patients.
@ast
Immune and viral correlates of ...... cally HIV-1 infected patients.
@en
Immune and viral correlates of ...... cally HIV-1 infected patients.
@nl
type
label
Immune and viral correlates of ...... cally HIV-1 infected patients.
@ast
Immune and viral correlates of ...... cally HIV-1 infected patients.
@en
Immune and viral correlates of ...... cally HIV-1 infected patients.
@nl
prefLabel
Immune and viral correlates of ...... cally HIV-1 infected patients.
@ast
Immune and viral correlates of ...... cally HIV-1 infected patients.
@en
Immune and viral correlates of ...... cally HIV-1 infected patients.
@nl
P2093
P2860
P50
P1433
P1476
Immune and viral correlates of ...... cally HIV-1 infected patients.
@en
P2093
Céline Merlin
Ellen Van Gulck
Guido Vanham
Leo Heyndrickx
Lotte Bracke
Sandra Coppens
P2860
P304
P356
10.1371/JOURNAL.PONE.0037792
P407
P577
2012-05-30T00:00:00Z